SMART DAK Cervical Cancer Screening
0.0.1 - ci-build
SMART DAK Cervical Cancer Screening, published by Dan Heslinga (independent contributor). This guide is not an authorized publication; it is the continuous build for version 0.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/dhes/smart-dak-cxca/ and changes regularly. See the Directory of published versions
The indicators encode A/641 (2020) Annex 2 metrics as machine-readable FHIR Measure resources, plus methodology-contribution indicators that surface programme realities the standard Annex 2 metrics do not (notably loss-to-follow-up cascade completion). The xlsx form is deferred to a future iteration.
The active indicator artifacts (7 Measures):
| Indicator | A/641 source | Type | Artifact |
|---|---|---|---|
| CXCA.IND.01 — Coverage at age 35 | Annex 2 #6 | proportion | Measure-CXCAIND01 |
| CXCA.IND.02 — Cascade completion (NotDone-aware) | methodology contribution | proportion with NumeratorExclusion | Measure-CXCAIND02 |
| CXCA.IND.03 — Invitation attendance rate | Annex 2 #4 | proportion | Measure-CXCAIND03 |
| CXCA.IND.04 — Coverage at age 45 | Annex 2 #6 (second age) | proportion | Measure-CXCAIND04 |
| CXCA.IND.06 — HPV-positive result rate | Annex 2 #11 | proportion | Measure-CXCAIND06 |
| CXCA.IND.07 — Treatment completion rate | Annex 2 #12 | proportion | Measure-CXCAIND07 |
| CXCA.IND.08 — New cervical cancer cases by age | Annex 2 #13 | continuous-variable | Measure-CXCAIND08 |
CXCA.IND.02 is the methodology-contribution measure — see Adapting Guidelines for Country Use for the cascade-completion rationale, which uses the Phase 4 NotDone profile to distinguish documented loss-to-follow-up from absent records. The remaining Annex 2 indicators (#5 cytology cycle coverage, #9 first-time-screening level, #10/11 raw counts, #14 cancer-suspected care completion) follow the same trio pattern (CQL + Library + Measure) and are deferred to later iterations.
For machine-readable presentation see Indicators and Measures.